Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26F7TT1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,296
Award facts
- Contract value 100% obligated
- $14,296.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $14,296.14 under a firm fixed-price contract. The delivery order, which represents no set-aside designation, is due for completion by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a specialty pharmaceutical used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to meet DLA requirements through competitive procurement processes and maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7TT1?
SPE2DR26F7TT1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F7TT1 worth?
The government has obligated $14,296 on SPE2DR26F7TT1.
Is contract SPE2DR26F7TT1 an order under another contract?
Yes. SPE2DR26F7TT1 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7TT1 competed?
The extent of competition for SPE2DR26F7TT1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award